Key result
Plasma presepsin levels were investigated for their diagnostic ability as a marker of systemic inflammation in patients with decompensated heart failure.
Why the study?
Does plasma presepsin (PSP) level have diagnostic ability in patients with decompensated heart failure?
Does plasma presepsin (PSP) level have diagnostic ability in patients with decompensated heart failure?
Supports presepsin evaluation in decompensated HF; leaves open diagnostic utility pending validation.
Objective: Recently, the soluble CD14 subtype; presepsin (PSP) has been suggested as a reliable marker for systemic inflammation, which has not been studied in decompensated heart failure (DHF) up to date. Our aim was to investigate plasma PSP levels and its diagnostic ability in patients with DHF.
No takes yet. Share an insight, caveat, or question.
Bıyık et al. (2018) studied this question. Plasma presepsin levels were investigated for their diagnostic ability as a marker of systemic inflammation in patients with decompensated heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: